Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hemozoin biocrystallization pathway is a critical biological process in malaria parasites, responsible for detoxifying free heme released during hemoglobin digestion inside infected red blood cells. Free heme (ferriprotoporphyrin IX) is highly toxic. Since *Plasmodium* lacks the enzyme heme oxygenase, it converts toxic heme into an inert crystalline form called hemozoin through a unique biocrystallization process involving heme aggregation and crystal formation within the parasite's food vacuole. Heme Detoxification Protein (HDP) plays a critical role in catalyzing this process. The unique nature of this pathway—absent from humans—and its essentiality make it an attractive target for antimalarial drugs.
Inhibition of β-hematin formation, disruption of heme detoxification
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemozoin Biocrystallization Pathway (N/A).